The GIFT Nifty futures, which is an early indicator of the Nifty50 index stocks, was trading higher by 150 points at 23,553, indicating that the domestic benchmark indices are likely to make a positive start on Tuesday. 

Earlier on Monday, 2 November, the domestic benchmark indices S&P BSE Sensex soared by 1,233 points or 1.66%, and settled at 75,692 while the Nifty50 traded 1.68% higher by 387 points, closing at 23,440.

Here are some stocks that are likely to remain in focus on 3 November.

NBCC (India): The company has signed a Memorandum of Understanding (MoU) with various departments of the Bihar government to undertake four redevelopment projects in Patna under Phase I. The projects will follow a self-financing model and will not require budgetary support from the state government.

Lupin: The company has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amifampridine Tablets, 10 mg. The tablets are bioequivalent to Catalyst Pharmaceuticals’ reference drug, Firdapse Tablets. Lupin is among the first companies to receive approval for this generic version and is eligible for 180 days of shared generic exclusivity.

Samvardhana Motherson International: The Motherson Group has partnered with Nanyang Technological University, Singapore (NTU Singapore), to develop and commercialise Spinheat, a magnetic induction technology that can cure industrial coatings within minutes while using significantly less energy than conventional oven-based methods.

Tired of missing hot stocks? Tradz by EquityPandit provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!